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Abstract
Psoriasis is a chronic skin condition that is indicated by red, patchy and scaly skin that
can be painful when irritated. Patients with psoriasis have an increased risk for a number of
chronic diseases. Despite the expansion of treatments for moderate-to-severe psoriasis over the
last decade, patients may still find that treatment strategies are not as successful, leaving them
dissatisfied with their treatments. A relationship built upon trust between the nurse and the
patient diagnosed with psoriasis may serve to help ensure optimal care.
A comprehensive literature review was performed and found that best practices for
patient management need to include education that covers information regarding treatments,
biological therapies, optimizing patient fidelity to treatment, and management of other side
effects/ comorbidities.
A study is proposed to investigate the impact of the nurse-patient relationship on patients’
perceptions about their disease management in relation to psoriasis and outcomes of care.
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Introduction
Psoriasis is a chronic skin condition that is indicated by red, patchy and scaly skin that
can be painful when irritated. Patients with psoriasis have an increased risk for more than one
chronic disease such as Psoriatic Arthritis, Crohn’s Disease, Psychological Disorders,
Hypertension, Diabetes, and Heart Disease, which may emerge due to the buildup of plaques
along with chronic inflammation (Aldredge, & Young, 2016). Despite the expansion of
treatments for moderate-to-severe psoriasis over the last ten years, alleviation of symptoms
remains suboptimal.
Patients often find that their therapies are not as successful, leaving them dissatisfied with
their treatments (Takeshita et al., 2014). A trusting relationship between the nurse and the patient
diagnosed with psoriasis must be built to ensure optimal and appropriate plans of care.
In this thesis, a comprehensive literature review was performed and found that best
practices for patient management need to include education that covers information regarding
treatments, biological therapies, optimizing patient fidelity to treatment, and management of
other side effects and comorbidities.
A qualitative study of patients and nurses is proposed to investigate the impact of the
nurse-patient relationship on patients’ perceptions about the disease management in relation to
psoriasis and outcomes of care. In addition, the proposed study will explore patients' and nurses"
perceptions of experiences that contribute to exacerbation and strategies that may work to
improve symptoms and quality of life.
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Literature Review
The research literature was searched by looking through the various databases using the
Dominican University of California’s Library, including MedLine, IceBerg, CINAHL, and
Elsevier. Seven primary research articles were compiled to review the issue of psoriasis.
Keywords included: psoriasis, chronic, stress, Psoriasis Area and Severity Index, psychological
distress, Quality of life and Dermatology Life Quality Score Index.
The literature review section of this paper is divided into two categories. The first
category notes the overlying causes of psoriasis and shows how psoriasis is exacerbated. The
second category goes into the treatments (pharmacological and nonpharmacological) available
for a person who has moderate-to-severe plaque psoriasis. Please see Appendix A for a table
summarizing the studies.
Psoriasis: Causes & Exacerbation
The Role of Stress in Children with Psoriasis
The article The Role of Stress in Children with Psoriasis by Manolache, L., PetrescuSeceleanu, D., & Benea, V. (2012) is an observational study that was to make note of any
stressful situations that happen before or after the onset of psoriasis in children that were 16
years of age or younger. This article was drawn from the database Sagepub from the National
Psoriasis Foundation. Some of the keywords that were used were psoriasis; stress; and children.
The sample size used was Boys (n=18) and Girls (n=23) with a total of (n=41) who are 16 years
old or less within the study. Data was collected from 2001 to 2007. The design of the study is
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comparative/ correlational where the author attempted to observe if stress is one of the main
factors of psoriatic flares between boys and girls.
The purpose of this article was to study was to observe if there were any stressful
situations within children’s lives which contributed to the extension or onset of their psoriasis.
The findings from the article suggest that the incidence of psoriasis among other new
dermatological conditions or morbidities was 0.43% , noting that the average age of children was
11.97 years (Manolache, Petrescu-Seceleanu, & Benea, 2012). In 29.26% of the cases, a family
history of psoriasis was accounted. 31% of the children with psoriasis had a flare up less than 3
months before the evaluation and 38% had recently had new occurrences or extensions
(Manolache, Petrescu-Seceleanu, & Benea, 2012). 14.6% of the cases noted that inflammation
was a focus and 41% of the cases noted that stress was a factor in contribution to their psoriasis
(Manolache, Petrescu-Seceleanu, & Benea, 2012). Most of these children mentioned at least one
event that may have affected their development of psoriasis. Boys with guttate lesions and girls
with psoriasis vulgaris were most affected by stress. Family problems such as disputes, illnesses,
financial restrictions, and death were often brought up under the stress category. It is also noted
that school plays a factor which influences psoriatic lesions.
The nursing implication for this article shows the importance of making sure patients are
stress free hospitalized or not, to help to contribute in the slowing/ healing process of their
psoriasis. A nurse-patient relationship must be built in order to maintain optimum levels of
rapport. One limitation of this article notes that the recollection of past events from the patient or
the patient’s family may not be consistent. In conclusion, the presence of stressful situations can
be considered influential in the extension of psoriasis in children.
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Association Between Psoriasis and Health-Related Quality of Life
The article The Association Between Psoriasis and Health-Related Quality of Life,
Work, Productivity, and Healthcare Resource use in Brazil by DiBonaventura, M., Carvalho, A.,
Souza, C., Squiassi, H., & Ferreira, C. (2018, March) is a quantitative study/ survey which
helped to monitor the correlation between psoriasis and the psychological/ humane and lucrative
burden among the people living in Brazil. The article was taken from the database PubMed from
the National Center for Biotechnology Information. Some of the keywords that were used were
Psoriasis; Health Impact Assessment; Quality of Life and Health Resources. The sample size
used were (n=12,000) Surveys which were given to people to assess work productivity, available
healthcare resources, and quality of life with present psoriasis skin conditions vs. no present skin
condition. Data was collected in 2012 using the Brazil 2012 National Health and Wellness
Survey (NHWS), which was a survey which focused on the health of adults ages 18 and older in
Brazil. Use of the Internet combined with the Computer-Assisted Web Interviewing or CAWI
was needed to lower the bias rates of people who had access or no access to the internet
regarding the older population.
The purpose of this study was to use surveys to measure Sociodemographics, Health
History, Work and Activity Impairment, and Healthcare Resource Use among people who have
or do not have psoriasis within Brazil. Results show that a total of 210 people that responded had
a diagnosis of psoriasis (n=157, 42, and 11) (DiBonaventura, Carvalho, Souza, Squiassi, &
Ferreira, 2018). It was also noted that reports of mild, moderate, and severe forms of psoriasis
were present. (DiBonaventura, Carvalho, Souza, Squiassi, & Ferreira, 2018). These respondents
had noted low health utilities, with a decrease in efficiency at work, impairment of daily
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activities, and a low number of physician visits over the last six months (DiBonaventura,
Carvalho, Souza, Squiassi, & Ferreira, 2018). Physical health also deteriorated as severity of skin
disease increased. Psoriasis severity was no different when factors regarding utilization of
healthcare re- sources and work efficiency came into play, showing a high probability for
economic burden (DiBonaventura, Carvalho, Souza, Squiassi, & Ferreira, 2018).
The nursing implication for this article supports that stress is a huge factor in psoriatic
flares and shows a significant burden to patients who have psoriasis across both economic and
humanistic ends. Limitations of this article were that cost analyses were not examined and the
cross sectional patient responses may have bias. In conclusion, the study further verifies that life
stressors and psoriasis are not compatible.
The Associations Between Psychological Stress and Psoriasis: A Systematic Review
The article The Associations Between Psychological Stress and Psoriasis: A Systematic
Review by Thomas Stewart, Winnie Tong, and Margot Whitfeld (2018) is a correlational/
comparative study that tries to determine if there is a link between psychological stress as the
predictor and onset or extension of psoriasis. Their second objective was determining if there is a
relationship between the severity of psychological stress and severity of psoriasis. This article
was drawn from the database Wiley from the International Journal of Dermatology. Some of the
keywords used were psoriasis, stress, stress psychological; psychological distress; mental strain;
or mental distress. The sample size used were (n=19,617) people who were included in crosssectional, case-control, and cohort studies who were 16 years or older with a diagnosis of
psoriasis. Data was collected from 1987 to 2016.
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The purpose of this study was to find any links between the presence of psychological
stress and how it impacts psoriasis severity. The study extracted data based on factors such as
age, gender, other dermatological conditions, proportioning of patients with psychological stress
predicting, onset, recurrence, and severity of psoriasis with individual reports of stress measures
(MJ;, 2018). Results showed that the largest available epidemiological study noted 7992
diagnoses of psoriasis in Italy. 27% of these cases self reported that their psoriasis had been
triggered by “stressful events”(MJ;, 2018). The study also indicated that the influence of
psychological stress on psoriasis extension happened to another 35% of patients noting that the
onset had occurred during a “stressful period”, and that 66-71% stated their psoriasis was
significantly affected by stress (MJ;, 2018). Overall epidemiological rates of stress related
psoriasis range from 27-71% (MJ;, 2018).
The outcome of this article suggests that there is a significant correlation between
using psychological stress as a predictor of psoriatic extension periods. Limitations of this study
included the use of patients that were recruited from hospital outpatient departments which limit
validity. In addition, environmental stressors affect every individual differently in which stressful
events could be discriminated against.
Outcomes in Psoriasis Patients with Clear Versus Almost Clear Skin in the Clinical Setting
The article Patient-Reported Outcomes in Psoriasis Patients with Clear Versus Almost
Clear Skin in the Clinical Setting by Takeshita et al. (2014) compares the quality of life between
patients with clear skin vs. patients with psoriasis. This article was drawn from the database
Iceberg from the National Center for Biotechnology Information. Some of the keywords used
were Psoriasis; Quality of life; Dermatology Life Quality Index; Physician Global Assessment;
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and Psoriasis Area and Severity Index. The sample size used was (n=97) patients with clear skin
vs. (n=441) patients with almost clear skin with a total of (n=538). The design of the study was a
correlational/ Comparative study which consisted of 97 patients with clear skin and 441 patients
with almost clear skin but are receiving UV light therapy.
The purpose of this article was to observe and record the results of Dermatology Life
Quality Index Scores of patients with clear skin vs. almost clear skin (Takeshita et al., 2014). The
results showed that patients with clear skin noted psoriasis did not affect their quality of life
(relative risk 1.60; 95% confidence interval, 1.37–1.86) vs. versus people with almost clear skin
(Takeshita et al., 2014). Patients with clear skin also denied use of topical prescriptions (relative
risk 2.08; 95% confidence interval, 1.73–2.49) (Takeshita et al., 2014). Both men and women
were close to being equally balanced from the two groups. Majority of patients were Caucasian.
Alcohol consumption was significantly different with patients with clear skin reporting no
alcoholic drinks in the past year (45.4%) versus almost clear skin (27.4%) (p=0.001) (Takeshita
et al., 2014).
The nursing implication of this article supports that patients’ with psoriasis report lower
quality of life. Some limitations of this article suggest that the cross-sectional design does not
allow long term or longitudinal study. Topical medication use and quality of life were
significantly different between these two groups.
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Available treatments (pharmacological and nonpharmacological) for plaque psoriasis
Patient Satisfaction with Treatments for Plaque Psoriasis in Clinical Practice
The article Patient Satisfaction with Treatments for Moderate-to-Severe Plaque Psoriasis in
Clinical Practice by Horn et al. (2008) is an Online Survey/ Quantitative study which was to
measure the satisfaction of treatment among people diagnosed with psoriasis. This article was
taken from the database Iceberg from the National Center for Biotechnology Information. The
sample size used was taken from the Dermatology Clinical Effectiveness Research Network
which consisted of (n=1182) patients with moderate-to-severe psoriasis. The design of the study
was cross sectional/ comparative study which looked at treatment efficacy for moderate-tosevere psoriasis. The data was taken by 12 clinicians.
The purpose of this article was to measure overall satisfaction of treatment. The results
show that patients receiving biological therapies, UV light, and methotrexate prescriptions have
higher satisfaction scores (83.3). Patients only utilizing topical medications had lower scores
(66.7) (Horn et al., 2008).
The nursing implication for this article notes that patients who receive non-topical
medications have better satisfaction ratings as compared to patients who took topicals.
Limitations of this study show that a sample population was taken from a preset consumer panel
then using random sampling. The panel was to represent the whole Canadian population, but no
one in the panel was eligible and lived in the territories. Territorial population was not well
represented. In conclusion, there were noticeable differences found in treatment satisfaction
among different therapies for psoriasis with an emphasis on effectiveness and convenience.
Treatment decisions and guideline developments must be implemented to improve study.
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Efficacy and safety of apremilast in patients with plaque psoriasis of the scalp
The article Efficacy and safety of apremilast in patients with moderate to severe plaque
psoriasis of the scalp by (Voorhees et al., 2020) is a multicentered, double blind, randomized,
placebo-controlled study which was to evaluate the effectiveness of Apremilast (Otezla) for
people with moderate-severe psoriasis of the scalp (Voorhees et al., 2020). This article was taken
from the database Iceberg from the Journal of the American Academy of Dermatology. Some of
the keywords used were: apremilast; psoriasis; quality of life; itching; pruritus; and scalp. The
sample size used were (n=303) total randomized patients, (n=102), receiving placebo, (n=201)
receiving apremilast. Patients were at least 18 years or older. Data was collected from May 2017
to January 2019. The design of the study is a phase 3, multicentered, double blind, randomized,
placebo-controlled study (Voorhees et al., 2020).
The purpose of this article was to observe the safety and effectiveness of the medication
apremilast (Otezla) on people diagnosed with moderate-severe plaque psoriasis of the scalp. The
results show that patients who took apremilast vs. patient with the placebo achieved a (43.3% vs.
13.7$) clearance rate based on the Physician Global Assessment regarding severity of psoriasis
(Voorhees et al., 2020). There were also significant results based on the Scalp Itch NRS with
(47.1%) patients taking apremilast) noting that their itching has been reduced as compared to the
placebo group with (21.1%) (Voorhees et al., 2020). Whole Body Itch NRS also noted a (45.5%)
itch reduction in people who took the medication, as opposed to the placebo (22.5%) (Voorhees
et al., 2020). The Dermatology Quality of Life Index scores indicate that people who took the
medication apremilast noted that there was a significant difference in skin clearance (6.7) as
compared to the placebo group (3.8) noting little clearance of psoriasis (Voorhees et al., 2020).
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The nursing implications of this article indicate that use of apremilast can result in having
side effects of diarrhea (30.5%), nausea (21.5%), headaches (12.0%), and vomiting (5.5%)
(Voorhees et al., 2020). Limitations of this article are that people with mild psoriatic spread were
not indicated/ observed. In conclusion, this study shows a significant decrease in psoriatic spread
of the scalp vs. people who do not take the medication apremilast (Otezla).
Aggressive weight-loss program with a ketogenic phase for treatment of plaque psoriasis
The article Aggressive weight-loss program with a ketogenic induction phase for the
treatment of chronic plaque psoriasis by (Castaldo et al., 2020) is a single arm, open label trial
where they evaluate the effectiveness of a weight loss program with the integration of a
ketogenic diet for treatment of chronic plaque psoriasis. This article was taken from the database
Iceberg from ScienceDirect. Some of the keywords are chronic plaque psoriasis; PASI; ketogenic
diet; mediterranean diet; and weight loss. The sample size used was (n=37) adult patients who
were either overweight/ obese and have never used any medication besides topical creams. All
patients were diagnosed with chronic plaque psoriasis. The study consisted of 30% men and 70%
female. The design of the study is a single-arm, open clinical trial.
The purpose of this study was to observe the effects of a weight loss program combined
with the use of a ketogenic diet to be used as a first line treatment for chronic plaque psoriasis
(Castaldo et al., 2020). Methods show that all of the patients went through a ten week, two phase
weight loss program. The program consisted of four weeks of a protein sparing, very low calorie
ketogenic diet, and a six week hypocaloric Mediterranian-like diet (Castaldo et al., 2020). The
results show that there was an average body weight reduction of 12% (10.6 kg), strong reduction
in the Psoriasis Area and Severity Index (PASI) (> 50% and >75%), and overall better scores
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within itch severity and the Dermatology Life Quality Score Index (DLQI)(-13.4 points)
(Castaldo et al., 2020).
The nursing implications of this article show the correlation between obesity and the
spread of psoriasis influencing quality of life. Body image can be maintained through use of
consistent exercise, further reducing buildup of plaque psoriasis. Visceral adipose tissue is the
main source of adipocytokines, which stimulate the immune response. The use of a weight loss
program with a low-calorie ketogenic diet proves an effective treatment for psoriasis.

Proposal for Further Study
Overall Research Question and Rationale
The question that arises from the research is - what is the effect of nursing education on
patients who have moderate-to-severe plaque psoriasis and how it can be changed to further
implement a reduction on psoriatic flares and what are patient perceptions based on the different
amount of therapies available? According to the literature review, it seems that there is an
overwhelmingly strong focus on stress and how it affects people with psoriasis and makes their
flaring episodes worse. When we take in account the patient as a whole, looking at their vitals,
medical history, age, social background, economic standings (such as debt), employment, etc. We
can try and isolate the main causes of stress within the client and see if we could provide support
in order to reduce the overall spread of their psoriasis. In terms of medications, we also need to
observe strength of therapy and consistency for optimal effectiveness. The purpose of this study
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is to look at the nurse-patient relationship and how it affects the patient’s underlying skin
condition, while at the same time noting the consistency of treatments/ therapies. The author
hopes that this study can be beneficial for dermatological nurses and especially patients suffering
with plaque psoriasis to see potential results and get the help they need for faster clearance of the
disease.
Theoretical Framework
The theorist that most relates to this study is Faye G. Abdellah and her theory of PatientCentered Approaches to Nursing. Abdellah was the first nurse officer to earn the rank of a two
star Rear Admiral and was also the first nurse and woman to serve as a Surgeon Deputy General
during the Korean War (21 Nursing Problems). Her work within nursing was able to change the
focus from disease-centered to patient-centered care. The Patient Assessment of Care Evaluation
(also known as ADPIE) that she had developed is used across the United States and is considered
the standard among nursing care in modern society. Abdellah believes that health is a state
mutually exclusive of illness. She also states that there is no definition of health but points
toward a patient's overall health needs and grounded mental foundation in her description of
nursing as a service (21 Nursing Problems). Her goal of centering patient care ultimately looks at
what the patient is feeling “right now” instead of the progress of their disease or injury. For
psoriatic patients, this should be the standard that must be upheld because of how there are
plenty of factors that can affect their underlying skin condition.
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Primary Research Aims
-

To observe nurse-patient relationship quality and status of psoriasis

-

Note effectiveness and consistency of pharmacological and nonpharmacological therapies
for psoriasis

Ethical Considerations
The proposed study will be reviewed for ethical considerations a by the university and the
facilities internal review board before data collection begins. After approval, potential
participants will be informed of their rights and provided information about the study. The study
will ensure the privacy of clients and nurses who participate in the study. Informed consent will
be obtained. Clients have the right to withdraw from the study if they choose. The nurse and
client must agree to keep all information confidentiality. Confidentiality of the research study
data will be ensured.

Research Method
Type of Study
Descriptive - Phenomenology Qualitative Study involving the patient with psoriasis and the
dermatological nurse working in conjunction with the said patient. This study will be
conducted by using interviews to find out about each client’s quality of life living with
psoriasis. The client's nurse also can give insight on various strategies they can implement
when caring for these patients.
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Therefore, after the study is explained, questions answered, and informed consent
obtained, clients and their nurses will be interviewed as a dyad whenever possible. If the
interviews cannot take place with both client and nurse present at the same time, then clients
and nurses will be interviewed separately.
The interviews will use qualifying questions to narrow the target population and see if
they are eligible for an interview, such as whether or not the person has been diagnosed with
psoriasis, length of time since initial diagnosis, location of residence (in San Francisco or
not), whether or not the client's age is greater than 18 years, status as student or working
adult, or if the potential participant a nurse who cares for the psoriasis clients.
Sample
1) Patients diagnosed with psoriasis - Inclusion criteria:
-

Any patient with moderate-to-severe plaque psoriasis lasting for at least 5 years

-

Patient must live in the San Francisco Bay Area

-

Minimum age = 18

-

Student or working adult

-

Any socioeconomic status

2) Nurses who care for clients diagnosed with psoriasis - Inclusion criteria:
-

Any nurse working with an eligible patient

Proposed Sample Size
-

The proposed sample size of this study is 10 patients diagnosed with psoriasis and 10
nurses who care for patients diagnosed with psoriasis
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Strategy for Recruitment
Once the clients who are eligible for the interview are selected, they will be asked to meet
on a mutually convenient date to conduct the interview. Clients who are eligible but are in the
hospital will be able to have a one-on-one interview with the researcher. The semi-structured
interviews will ask questions regarding certain stressors in the client's life such as
socioeconomic status, employment status, social and family history, therapies
(pharmacological and non-pharmacological), and progression of psoriasis. The client's nurse
may also be interviewed and asked to offer nursing strategies to alleviate psoriasis symptoms
and help the researcher gather insights. The interviews are expected to last approximately 45
minutes.
Data Analysis
A qualitative content analysis will be performed, including:
-

Identification of similar words and phrases

-

Organization into categories

-

Description of themes

Conclusion
The review of the research literature revealed several common threads. These include:
● Stress may be a precipitator of symptoms and exacerbation
● The problem may be more prevalent among patients of low socioeconomic class
● Lack of knowledge regarding therapies is often cited as a need
● Limiting the severity of psoriatic flares is an ongoing need.
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Furthermore, effective communication and encouragement of patient receptiveness are
essential for understanding patient needs within the nurse-patient relationship. Building
rapport early on within a patient's stay can further ease the patient to provide the optimal
care. In a clinical setting, nurses must be able to be empathetic to their patients to understand
their needs. If a patient has other problems other than their underlying medical conditions,
the nurse must be able to offer support/ point clients in the right direction through use of
other resources relating to economic support, psychiatric help, etc.
By questioning the nurse-patient relationship and observing the various therapies for
patients with psoriasis, this research could potentially help nurses become more effective in
caring for patients with this disease.
The proposed study aims to learn more about the economic statuses of clients affected.
There may be variability or bias within these results, so narrowing the target population could
prove much more beneficial for the study. A correlation must be found to further find an
observational target population.
In the future, a survey to compare patients’ perceptions of two different educational
programs, one in pharmacological therapies and the other in non-pharmacological therapies
may a reasonable step toward finding the most effective treatments for psoriasis.
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Multicenter, randomized, doubleblind, placebocontrolled study

For the placebo-controlled phase, study
personnel randomly
assigned patients (2:1),
using a permuted block
randomization and
centralized interactive
response technology, to
receive apremilast
30 mg twice daily or
placebo for 16 weeks.
To mitigate potential
gastrointestinal adverse
effects, doses were
titrated over the first
week of treatment (in
10-mg increments). At
week 16, all patients
continued or switched
to apremilast 30 mg
twice daily through
week 32, with dummy
titration or titration
during week 16 for
patients initially randomized to apremilast
or placebo, respectively.
The study sponsor, site,
contract research
organization personnel,
and patients were
blinded to treatment
allocation through
week 16; after week 16,
the study sponsor, site,
and contract research
organization personnel
directly involved with
study conduct remained blinded until
the final database lock.
The study drug was
administered twice
daily, approximately
12 hours apart, without
restriction of food or
drink

There were 303
randomized patients (placebo:
n = 102; apremilast: n = 201).
With apremilast,
significantly more
patients achieved
Scalp Physician
Global Assessment
(43.3% vs 13.7%),
Scalp Itch NRS
(47.1% vs 21.1%),
and Whole Body
Itch NRS (45.5%
vs 22.5%) response, and significantly greater
DLQI improvement was observed versus
placebo (-6.7 vs
-3.8; all P < .0001).
Common adverse
events with
apremilast were
diarrhea (30.5%),
nausea (21.5%),
headache (12.0%),
and vomiting
(5.5%).
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the reliability and
correlation of the
study.
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To evaluate the
efficacy and safety
of apremilast for
moderate to severe scalp psoriasis.

n = 303

